Home

Dykker Parcel Hound servier mediator Men søsyge Datum

At the end of the Mediator appeal trial, Servier proclaims one last time  its "good faith" -
At the end of the Mediator appeal trial, Servier proclaims one last time its "good faith" -

Jacques Servier, 92, Dies; Accused of Hiding the Risks of Drugs - The New  York Times
Jacques Servier, 92, Dies; Accused of Hiding the Risks of Drugs - The New York Times

Scandale du Mediator : les laboratoires Servier condamnés pour « tromperie  aggravée » et « homicides involontaires »
Scandale du Mediator : les laboratoires Servier condamnés pour « tromperie aggravée » et « homicides involontaires »

French pharma firm guilty of manslaughter and deception over deadly Mediator  drug | Euronews
French pharma firm guilty of manslaughter and deception over deadly Mediator drug | Euronews

Mediator : « Pas de Légion d'honneur pour Jacques Servier », réclament  Irène Frachon et Éric Giacometti
Mediator : « Pas de Légion d'honneur pour Jacques Servier », réclament Irène Frachon et Éric Giacometti

Sportello dei diritti - dalla parte dei cittadini - Drug "Mediator" means a  killer pill sold in Italy in France was withdrawn after causing 500 to 2000  deaths.
Sportello dei diritti - dalla parte dei cittadini - Drug "Mediator" means a killer pill sold in Italy in France was withdrawn after causing 500 to 2000 deaths.

Jacques Servier, maker of diet drug linked to deaths, might face charges |  South China Morning Post
Jacques Servier, maker of diet drug linked to deaths, might face charges | South China Morning Post

Trial opens in France over weight loss drug that 'killed hundreds'
Trial opens in France over weight loss drug that 'killed hundreds'

Servier anklaget for uagtsomt manddrab i omfattende retssag om fedmemiddel  — MedWatch
Servier anklaget for uagtsomt manddrab i omfattende retssag om fedmemiddel — MedWatch

Affaire du Mediator : les enjeux du second procès qui s'ouvre ce lundi - Le  Parisien
Affaire du Mediator : les enjeux du second procès qui s'ouvre ce lundi - Le Parisien

Servier, lab founder in drug scandal, dies at 92
Servier, lab founder in drug scandal, dies at 92

Servier guilty of manslaughter over deadly weight loss pill
Servier guilty of manslaughter over deadly weight loss pill

Paris court convicts, fines pharma firm for deadly diet pill | AP News
Paris court convicts, fines pharma firm for deadly diet pill | AP News

Diabetes drug victims demand justice in French trial | CTV News
Diabetes drug victims demand justice in French trial | CTV News

Jacques Servier, left, founder of Servier Laboratories, sits during the  opening of the trial of the so-called Mediator case, a drug linked to  hundreds of deaths, at Nanterre's court house, outside Paris,
Jacques Servier, left, founder of Servier Laboratories, sits during the opening of the trial of the so-called Mediator case, a drug linked to hundreds of deaths, at Nanterre's court house, outside Paris,

Landmark French trial over slimming drug Mediator back in court
Landmark French trial over slimming drug Mediator back in court

France's Servier finally goes on trial over Mediator safety scandal |  pharmaphorum
France's Servier finally goes on trial over Mediator safety scandal | pharmaphorum

Procès en appel du Mediator : on vous explique pourquoi l'affaire revient  devant la justice
Procès en appel du Mediator : on vous explique pourquoi l'affaire revient devant la justice

Mediator : autopsie d'un scandale de santé publique | Les Echos
Mediator : autopsie d'un scandale de santé publique | Les Echos

Procès du Mediator - Servier condamné - Actualité - UFC-Que Choisir
Procès du Mediator - Servier condamné - Actualité - UFC-Que Choisir

French pharma firm found guilty over medical scandal in which up to 2,000  died | France | The Guardian
French pharma firm found guilty over medical scandal in which up to 2,000 died | France | The Guardian

Mediator (diabetes drug)
Mediator (diabetes drug)

The whistleblowing doctor who took on French pharma giant over 'killer'  drug | Mediapart
The whistleblowing doctor who took on French pharma giant over 'killer' drug | Mediapart